A Study to Investigate the Safety, Tolerability, and PK of AB102 in Healthy Participants
Clinical trial NCT07662057 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07662057
- Sponsor
- Arcus Biosciences, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2026-12-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.